Skip to content

Adverse drug events leading to emergency department visits: A multicenter observational study in Korea

Document Type
Publications · Journal Article
Registered DB
SCIEScopus
Journal Ranking
JCR Q2Scopus Q1
Journal
PLOS ONE17(9) · pp.e0272743 · 2022
Citation
Web of Science 15Scopus 12
FWCI (Scopus)
0.61
JCR IF
JCR 2021 3.752
ISSN
1932-6203

Authors

  1. Kang, Min-GyuFirst authorChungbuk Natl Univ Hosp, Dept Internal Med, Subdiv Allergy, Cheongju, South Korea
  2. Lee, Ju-YeunSeoul Natl Univ, Coll Pharm, Seoul, South Korea
  3. Woo, Sung-IlChungbuk Natl Univ Hosp, Dept Pediat, Subdiv Allergy, Cheongju, South Korea
  4. Kim, Kyung-SookChungbuk Natl Univ Hosp, Dept Pharm, Cheongju, South Korea
  5. Jung, Jae-WooCorresponding authorChung Ang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  6. Lim, Tae HoHanyang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea
  7. Yoon, Ho JooHanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea
  8. Kim, Chan WoongChung Ang Univ, Dept Emergency Med, Coll Med, Seoul, South Korea
  9. Yoon, Hye-RanDuksung Womens Univ, Coll Pharm, Seoul, South Korea
  10. Park, Hae KyungPusan Natl Univ, Dept Internal Med, Sch Med, Busan, South Korea
  11. Kim, Sang-HeonCorresponding authorHanyang Univ, Dept Internal Med, Coll Med, Seoul, South Korea

Abstract

Adverse drug events are significant causes of emergency department visits. Systematic evaluation of adverse drug events leading to emergency department visits by age is lacking. This multicenter retrospective observational study evaluated the prevalence and features of adverse drug event-related emergency department visits across ages. We reviewed emergency department medical records obtained from three university hospitals between July 2014 and December 2014. The proportion of adverse drug events among total emergency department visits was calculated. The cause, severity, preventability, and causative drug(s) of each adverse drug event were analyzed and compared between age groups (children/adolescents [<18 years], adults [18-64 years], and the elderly [≥65 years]). Of 59,428 emergency department visits, 2,104 (3.5%) were adverse drug event-related. Adverse drug event-related emergency department visits were more likely to be female and older. Multivariate logistic regression analysis revealed that compared to non- adverse drug event-related cases, adverse drug event-related emergency department visitors were more likely to be female (60.6% vs. 53.6%, p<0.001, OR 1.285, 95% CI 1.025-1.603) and older (50.8 ± 24.6 years vs. 37.7 ± 24.4 years, p<0.001, OR 1.892, 95% CI: 1.397-2.297). Comorbidities such as diabetes, chronic kidney disease, chronic liver disease, and malignancies were also significantly associated with adverse drug event-related emergency department visits. Side effects were the most common type of adverse drug events across age groups, although main types differed substantially depending on age. Serious adverse drug events, hospitalizations, and adverse drug event-related deaths occurred more frequently in the elderly than in adults or children/adolescents. The proportion of adverse drug event-related emergency department visits that were preventable was 15.3%. Causative drugs of adverse drug events varied considerably depending on age group. Adverse drug event features differ substantially according to age group. The findings suggest that an age-specific approach should be adopted in the preventive strategies to reduce adverse drug events.

Keywords

NATIONAL SURVEILLANCEHOSPITAL ADMISSIONSGENDER-DIFFERENCESSEXPOLYPHARMACY

Identifiers

Scopus EID
2-s2.0-85138457986
WoS UID
000896866300001